SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-005174
Filing Date
2019-08-06
Accepted
2019-08-05 20:38:21
Documents
10
Period of Report
2019-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_080519.htm 6-K 10996
2 EXHIBIT 99.1 exh_991.htm EX-99.1 281754
3 EXHIBIT 99.2 exh_992.htm EX-99.2 1547
4 EXHIBIT 99.3 exh_993.htm EX-99.3 1623
5 GRAPHIC logo.jpg GRAPHIC 24399
6 GRAPHIC performance_graph.jpg GRAPHIC 52542
7 GRAPHIC exh992_1.jpg GRAPHIC 103968
8 GRAPHIC exh992_2.jpg GRAPHIC 99726
9 GRAPHIC exh993_1.jpg GRAPHIC 121618
10 GRAPHIC exh993_2.jpg GRAPHIC 94543
  Complete submission text file 0001171843-19-005174.txt   981964
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 191000201
SIC: 2834 Pharmaceutical Preparations